11282-Lymphomas-Hodgkins-580

Lymphomas

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Address

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.